-

Ringing in the New Year With a New Name! Shinkowa Pharmaceutical Co., Ltd., Is Now MIRAILAB BIOSCIENCE Inc.

TOKYO--(BUSINESS WIRE)--Since 2016, Shinkowa Pharmaceutical Co., Ltd., has been proud of its work as a bio-venture company, convinced of the infinite possibilities of science, and experiencing the joy of realizing such possibilities in our own laboratories one by one, year by year.

Each year we look back upon, adding to our knowledge and experience, and cherishing each accomplishment, the more we see in our future and the more we are inspired to achieve in years to come. So powerful has this inspiration become, and so close to our hearts, that as of January 1, this year, Shinkowa Pharmaceutical Co., Ltd., has taken a new name:

MIRAILAB BIOSCIENCE Inc.
https://en.mirailab-bio.com/

“Mirai” means “future” in Japanese. Our new name reflects our ever-increasing feeling of hope for the future, our passion to reach greater goals, and our commitment to realize the new possibilities that emerge from every development and discovery.

We are grateful to all our customers and stakeholders who share in and support us in our new name’s spirit!

MIRAILAB BIOSCIENCE Inc.
Megumi Tanaka, CEO

Contacts

Inquiries:
MIRAILAB BIOSCIENCE Inc.
Public Relations
Ayuko Matsuda
E-mail: info@mirailab-bio.com

MIRAILAB BIOSCIENCE Inc.



Contacts

Inquiries:
MIRAILAB BIOSCIENCE Inc.
Public Relations
Ayuko Matsuda
E-mail: info@mirailab-bio.com

More News From MIRAILAB BIOSCIENCE Inc.

Mirailab Bioscience: Notice of Acquisition of Chinese Patent Rights for "Food or beverage for babies and infants, method for improving intestinal environment of baby or infant, and method for enhancing immunity of baby or infant"

TOKYO--(BUSINESS WIRE)--Mirailab Bioscience Inc. (Head office: Chuo-ku, Tokyo, CEO: Megumi Tanaka) has obtained patent rights in China for "Food or beverage for babies and infants, method for improving intestinal environment of baby or infant, and method for enhancing immunity of baby or infant" which had been pending a patent (PCT) international application. Patent Summary Application No. : PCT/JP2020/004947 (Chinese Patent 113438896) Name of invention (in English): Food or beverage for babies...

World’s First NMN Supplement Manufacturer, MIRAILAB BIOSCIENCE, Launches NMN Supplements and Cosmetics in Singapore

TOKYO--(BUSINESS WIRE)--MIRAILAB BIOSCIENCE Inc. (Headquarters: Chuo-ku, Tokyo; CEO: Megumi Tanaka) has entrusted Global Ocean Distribution Pte Ltd (Headquarters: Circular Road; Director: Getty Poon) with the sales of its original supplement brand “MIRAI LAB,” which contains β-Nicotinamide Mononucleotide (β-NMN). The supplements are now available for purchase on Shopee, one of Singapore's major e-commerce platforms. NMN is a nutrient widely studied around the world for its potential effects on...

World’s First NMN Manufacturer, MIRAILAB BIOSCIENCE, Launches NMN Supplements and Cosmetics in UAE

TOKYO--(BUSINESS WIRE)--MIRAILAB BIOSCIENCE Inc. (Headquarters: Chuo-ku, Tokyo; CEO: Megumi Tanaka) has launched sales of its original supplement brand “MIRAI LAB,” which contains β-Nicotinamide Mononucleotide (β-NMN), is now available in the UAE. NMN is a nutrient widely researched worldwide for its potential effects on anti-aging and rejuvenation. It has garnered significant media attention for its promising properties. MIRAILAB BIOSCIENCE company offers a range of products designed to promot...
Back to Newsroom